July 7, 2008 - OrbusNeich today said data recently presented at the 17th Annual Meeting of the Japanese Society of ...
July 7, 2008 - InTouch Technologies Inc. today launched a new product feature, StrokeRESPOND, to extend the ...
July 3, 2008 - A multicenter trial with up to five years of follow-up continues to support the mid- and long-term durability and safety of the Zenith endovascular graft used for aneurysm repair.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Boston Scientific Corp. offers the PROMUS Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific under an agreement executed prior to the 2006 acquisition of the former Guidant Corp. by Boston Scientific.
July 3, 2008 - A unanimous federal jury in Texas recently found that two patents exclusively licensed to Pressure Products Medical Supplies Inc., which cover medical products called valved peel-away introducers used for placement and implantation of pacemaker leads, were valid and infringed by the FlowGuard and ViaSeal products marketed by Quan Emerteq Corp.
July 2, 2008 - The Society for Cardiovascular Angiography and Interventions (SCAI), the leading professional ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 1, 2008 - The impact of surgeons' annual aortic volume and other prognostic indicators have been revealed in early outcomes of ruptured abdominal aortic aneurysm (RAAA) repair in a recent study from the University of Pittsburgh Medical Center. Details of the study have been published in the July issue of the Journal of Vascular Surgery.
July 3, 2008 - Boston Scientific Corp. today said the FDA has approved the PROMUS Everolimus-Eluting Coronary Stent ...
July 2, 2008 - The European Alliance for Access to Safe Medicines (EAASM) has today unveiled its comprehensive research report, “The Counterfeiting Superhighway,” which reveals that a frightening 62 percent of medicines purchased online are fake or substandard.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 1, 2008 - The FDA is asking healthcare professionals and facilities check all drug and device storage areas ...
July 1, 2008 - CryoCath Technologies introduced the Arctic Front in Italy, Belgium and Spain, aiming to provide better ...
July 1, 2008 - Toshiba Medical Systems Corp. (TMSC), the parent company of Toshiba America Medical Systems Inc ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 1, 2008 - An interventional cardiology team this week led by Professor Patrick W. Serruys, M.D., Ph.D, successfully ...
July 1, 2008 - American TeleCare Inc. (ATI) said today NuPhysicia LLC adopted ATI's CareTone Ultra digital stethoscope ...
June 30, 2008 - Kimberly-Clark Health Care said today it received an agreement from Novation to offer its alliance ...